Loading...

Cardiol Therapeutics Inc.

CRDL•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$1.40
$0.04(2.94%)
U.S. Market opens in NaNh NaNm

Cardiol Therapeutics Inc. (CRDL) Stock Overview

Explore Cardiol Therapeutics Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap156.4M
P/E Ratio-5.73
EPS (TTM)$-0.29
ROE-2.38%
Fundamental Analysis

AI Price Forecasts

1 Month$0.75
3 Months$1.59
1 Year Target$0.34

CRDL Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cardiol Therapeutics Inc. (CRDL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 54.57, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.34.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -5.73 and a market capitalization of 156.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.94%
5-Day Change
-2.10%
1-Month Change
33.33%
3-Month Change
34.62%
6-Month Change
17.65%
Year-to-Date (YTD) Change
46.78%
1-Year Change
30.84%
3-Year Change
100.03%
5-Year Change
-56.11%
All-Time (Max) Change
-62.58%

Contact Information

https://www.cardiolrx.com
289 910 0850
2265 Upper Middle Road East, Oakville, ON, L6H 0G5

Company Facts

18 Employees
IPO DateJan 15, 2019
CountryCA
Actively Trading

Frequently Asked Questions